510(k) K213858

LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus by DiaSorin, Inc. — Product Code NXO

K213858 is an FDA 510(k) premarket notification submitted by DiaSorin, Inc. for the device "LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus". The FDA issued a decision of Substantially Equivalent on Jul 26, 2022. The device falls under product code NXO (Calprotectin, Fecal), a Class II device regulated under 21 CFR 866.5180. DiaSorin, Inc. has 73 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jul 26, 2022
Date Received
Dec 10, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Calprotectin, Fecal
Device Class
Class II
Regulation Number
866.5180
Review Panel
IM
Submission Type
510(k)

The device is used for the measurement, in human stool, of fecal calprotectin, a neutrophilic protein that is a marker of mucosal inflammation. The device can be used as an aid in the diagnosis of inflammatory bowel disease (ibd), crohn's disease and ulcerative colitis and to differentiate ibd from irritable bowel syndrome.

Need the full FDA record for DiaSorin, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K213858. Report a data issue: hello@regdatalab.com.